• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深静脉血栓形成患者中的隐匿性恶性肿瘤

Occult malignant neoplasm in patients with deep venous thrombosis.

作者信息

Goldberg R J, Seneff M, Gore J M, Anderson F A, Greene H L, Wheeler H B, Dalen J E

出版信息

Arch Intern Med. 1987 Feb;147(2):251-3.

PMID:3813741
Abstract

An association between venous thrombosis and cancer was first suggested by Armand Trousseau and subsequently confirmed by multiple postmortem studies. In a previous study, patients with pulmonary embolism, as assessed by pulmonary angiography, were at significantly increased risk of occult cancer with a comparison group of patients without pulmonary embolism. This nonconcurrent prospective epidemiologic study extends these findings by demonstrating a significantly increased risk of occult cancer in patients with deep venous thrombosis (DVT) confirmed by impedance plethysmography as compared with those with suspected DVT in whom the diagnosis was ruled out. Differences in the incidence of malignant neoplasms were greatest within the first two years after the diagnosis of DVT, and patients younger than 50 years with venous thrombosis were at particularly increased risk of occult cancer (relative risk, 19.0). These findings indicate that all patients with DVT or pulmonary embolism should have an appropriate diagnostic workup and careful follow-up, particularly with regard to the risk of occult cancer.

摘要

静脉血栓形成与癌症之间的关联最早由阿尔芒·特鲁索提出,随后多项尸检研究证实了这一点。在之前的一项研究中,经肺血管造影评估,肺栓塞患者患隐匿性癌症的风险显著高于无肺栓塞的对照组患者。这项非同期前瞻性流行病学研究扩展了这些发现,表明经阻抗体积描记法确诊为深静脉血栓形成(DVT)的患者患隐匿性癌症的风险显著高于疑似DVT但诊断被排除的患者。恶性肿瘤发病率的差异在DVT诊断后的头两年内最为明显,50岁以下的静脉血栓形成患者患隐匿性癌症的风险尤其增加(相对风险,19.0)。这些发现表明,所有DVT或肺栓塞患者都应进行适当的诊断检查和仔细的随访,尤其是考虑到隐匿性癌症的风险。

相似文献

1
Occult malignant neoplasm in patients with deep venous thrombosis.深静脉血栓形成患者中的隐匿性恶性肿瘤
Arch Intern Med. 1987 Feb;147(2):251-3.
2
The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.原发性深静脉血栓形成或肺栓塞后被诊断为癌症的风险。
N Engl J Med. 1998 Apr 23;338(17):1169-73. doi: 10.1056/NEJM199804233381701.
3
Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis.
Thromb Haemost. 1991 Mar 4;65(3):233-6.
4
[The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use?].[50岁以下静脉血栓栓塞患者隐匿性恶性肿瘤的发生情况:应采用哪些诊断性筛查方法?]
Vnitr Lek. 2004 Oct;50(10):751-5.
5
Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting.
Arch Intern Med. 1989 Mar;149(3):511-3.
6
Pulmonary embolism: incidence, diagnosis, prevention, and treatment.肺栓塞:发病率、诊断、预防及治疗
J Am Osteopath Assoc. 1985 Mar;85(3):176-85.
7
[Deep venous thrombosis and cancer in the elderly].[老年人深静脉血栓形成与癌症]
Minerva Med. 2001 Oct;92(5):307-13.
8
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.深静脉血栓形成的临床病程。对528例有症状患者的前瞻性长期随访。
Haematologica. 1997 Jul-Aug;82(4):423-8.
9
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins.在不增加血栓形成风险的情况下延迟对深静脉血栓形成和肺栓塞的客观评估:一种基于检测前临床模型、D-二聚体检测及低分子量肝素使用的实用方法
Arch Intern Med. 2004;164(22):2477-82. doi: 10.1001/archinte.164.22.2477.
10
Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.择期膝关节镜检查中深静脉血栓形成的发病率、自然史及危险因素
Thromb Haemost. 2001 Sep;86(3):817-21.

引用本文的文献

1
Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor.心血管危险因素对无明确危险因素的肺栓塞临床表现及生存情况的影响。
J Thorac Dis. 2020 Oct;12(10):5411-5419. doi: 10.21037/jtd-20-1634.
2
Thrombophilia screening revisited: an issue of personalized medicine.血栓形成倾向筛查再探:一个个体化医学的问题。
J Thromb Thrombolysis. 2020 May;49(4):618-629. doi: 10.1007/s11239-020-02090-y.
3
Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.
住院癌症患者静脉血栓栓塞症预防的新见解:一项前瞻性研究的启示。
PLoS One. 2018 Aug 2;13(8):e0200220. doi: 10.1371/journal.pone.0200220. eCollection 2018.
4
Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.评估非诱发性静脉血栓栓塞中隐匿性癌症的预后评分的验证。
PLoS One. 2018 Mar 20;13(3):e0194673. doi: 10.1371/journal.pone.0194673. eCollection 2018.
5
Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.18F-氟脱氧葡萄糖正电子发射断层扫描联合低剂量计算机断层扫描在不明原因静脉血栓栓塞症患者癌症筛查中的应用
PLoS One. 2017 Jun 1;12(6):e0178849. doi: 10.1371/journal.pone.0178849. eCollection 2017.
6
Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study.原发性静脉血栓栓塞症患者的癌症超额风险:一项基于全国人群的队列研究。
Br J Cancer. 2004 Jul 5;91(1):92-5. doi: 10.1038/sj.bjc.6601964.
7
Coagulation and cancer: implications for diagnosis and management.凝血与癌症:对诊断和管理的影响。
Pathol Oncol Res. 2000;6(4):301-12. doi: 10.1007/BF03187336.
8
Should we look further for cancer in a patient with venous thromboembolism?对于静脉血栓栓塞患者,我们是否应该进一步排查癌症?
West J Med. 2000 May;172(5):325-8. doi: 10.1136/ewjm.172.5.325.
9
Deep venous thrombosis and occult malignancy: an epidemiological study.深静脉血栓形成与隐匿性恶性肿瘤:一项流行病学研究。
BMJ. 1994 Apr 2;308(6933):891-4. doi: 10.1136/bmj.308.6933.891.
10
Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis.低分子量肝素与普通肝素在初始治疗深静脉血栓形成中的疗效和安全性比较:一项荟萃分析。
BMJ. 1994 Jul 30;309(6950):299-304. doi: 10.1136/bmj.309.6950.299.